Global Bovine Serum Albumin Market Size, Share, Trends & Growth Forecast Report – Segmented By Form (Dry, Liquid), Grade (Technical & Diagnostic-Grade, Research/Reagent-Grade, Food Grade), Vertical (Life Sciences Industry, Feed Industry, Food Industry, Research Institutes), And Region (North America, Europe, Asia Pacific, Latin America, And Middle East & Africa) - Industry Analysis (2025 To 2033)
The global bovine serum albumin market size was calculated to be USD 270.32 million in 2024 and is anticipated to be worth USD 352.71 million by 2033 from USD 278.43 million In 2025, growing at a CAGR of 3% during the forecast period. The demand for albumin in R&D activities is increasing and the non-therapeutic application of albumin is driving the market.
Albumin refers to a group of acidic proteins, with the primary function of controlling colloidal osmotic pressure in the blood. It is found not only in body fluids but also in the tissues and plants of mammals. Albumin is a type of protein found abundantly in plasma. Bovine serum albumin is isolated from cow's milk and is mainly used as a blocker in the Enzyme Immunosorbent Assay (ELISA) and Western blot, and it is used as a standard to calibrate proteins and dissolve lipids. Bovine serum albumin (BSA) or fraction V is the main plasma protein found in bovine blood that helps maintain the pH levels. It is an important by-product of the meat industry and is derived mainly from fetal serum. BSA is purified from serum through a variety of purification methods, such as low-temperature organic solvent fractionation, thermal shock, and ion exchange chromatography. It is also found in various proportions in milk and whey protein. This generally occurs because proteins escape from whey into milk as part of the secretion from the mammary glands. BSA is widely used in a variety of immunological, biochemical, and biotechnological applications. It is also used as a protein supplement and small molecule carrier for other cell culture applications. The global market for bovine serum albumin is growing as consumer preferences for high-protein diets change and the demands of the life sciences industry increase.
The growth of the global market is accelerating as albumin is applied in various fields, such as vaccines, media production, drug supply, etc. The increased prevalence of diseases leading to hypoalbuminemia, the surge in demand for albumin in the non-therapeutic industry, the increased demand for albumin for research and development, and the increased production of immunoglobin are some of the other factors responsible for the growth of this market. In addition, industry scientists prefer bovine serum albumin as it does not affect many biochemical reactions. It is relatively cheaper than other protein standards due to a large amount of blood. It can be easily purified from bovine blood. Some of the other properties that favor the products are increasing applications in the pharmaceutical and diagnostic industries, including very pure properties and high water solubility. The increased use of plasma products in the food industry, along with the advances in the collection and processing of livestock blood and the increased demand for meat and animal protein in the population are the main driving forces in the market.
The worldwide bovine serum albumin market is determined to expand rapidly. The continual research and development has augmented the development of the market with the introduction of new variants with different grades, such as enzyme grade and food grade to improve overall share. The global bovine serum albumin market is promoted by the surge in the utilization of plasma products in the food sector and the rising call for animal meat and protein among the populace. Other drivers of the market include expanding the range of animal by-products in cell culture technology, increasing demand as an excipient for the pharmaceutical industry, and improving the supply chain and distribution network. Bovine serum albumin is a nutrient that repairs tissues and aids growth and development and protects the body from viruses that cause infection and disease. These factors also increase the demand for bovine serum albumin in the global market. Rapid growth and expansion of albumin coverage in developing countries across the Asia Pacific are expected to provide revenue opportunities for players in the bovine serum albumin market.
The increase in bovine disease leads to a decrease in production and a greater preference for alternative products, which hinders the growth of the market. Strict regulations, limited reimbursements, and the irrational use and side effects associated with albumin are factors that inhibit the growth of this market. Another limitation of the market is the decrease in production due to the increase in bovine disease and a greater preference for alternative products.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 3% |
| Segments Covered | By Form, Grade, Vertical, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leaders Profiled | Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGAA, Itoham Yonekyu Holdings Inc, Proliant Biologicals, Kraeber & Co Gmbh, Rockland Immunochemicals Inc, Rocky Mountain Biologicals, Bio-Techne Corporation, Prospec-Tany Technogene Ltd and Others. |
The dry form of Bovine Serum Albumin (BSA) holds a significant share of the market due to its stability, longer shelf life, and ease of handling. Although specific market share data is not readily available, dry BSA is widely used in applications such as cell culture, drug delivery, and diagnostics. Its ability to be stored and transported efficiently compared to the liquid form makes it the preferred choice for industries requiring bulk quantities of BSA. The demand for long-term storage, cost-effectiveness, and convenience continues to position the dry form as the dominant segment in the BSA market.
The liquid form of BSA is the fastest-growing segment, projected to grow at a CAGR of 3.5% from 2024 to 2031. The ease of use of liquid BSA, requiring no reconstitution, makes it ideal for immediate application in laboratories and biopharmaceutical processes. Its adoption is increasing in cell culture, vaccine production, and diagnostic tests due to its convenience and time-saving benefits. Liquid BSA’s ability to be directly used without additional preparation steps positions it as a rapidly growing segment, catering to the increasing demand in the biopharmaceutical and life sciences sectors.
The largest segment of the bovine serum albumin (BSA) market is Fraction V, which holds approximately 60% of the market share. This dominance is due to its high purity, making it ideal for crucial applications in research, diagnostics, and biopharmaceutical production. Fraction V is widely used in cell culture media, immunoassays, and drug delivery systems, playing a vital role in advancing the biopharmaceutical and diagnostic industries. The growing demand for advanced research tools and diagnostic reagents continues to drive its significant market share, reflecting its importance in the global healthcare landscape.
The fastest-growing segment in the BSA market is the Asia Pacific region, which is projected to grow at a 16.5% CAGR from 2021 to 2030. This rapid growth is fueled by the expanding biopharmaceutical sector in countries like China, India, Japan, and South Korea. Government support, including increased funding for R&D and initiatives to strengthen the domestic biotech industry, has greatly contributed to this rise. Additionally, global pharmaceutical companies have established manufacturing hubs in China, addressing both local demand and international markets. The increasing need for BSA in biopharmaceutical applications and research further accelerates growth in this region.
The Life Sciences Industry is the largest segment in the bovine serum albumin (BSA) market, accounting for approximately 60% of the market share. This dominance is attributed to BSA's high purity, making it essential for critical applications such as research, diagnostics, and biopharmaceutical production. BSA is widely used in cell culture media, immunoassays, and drug delivery systems, playing a vital role in advancing the biopharmaceutical and diagnostic industries. The growing demand for advanced research tools and diagnostic reagents continues to drive its significant market share, reflecting its importance in the global healthcare landscape.
The Asia Pacific region is the fastest-growing segment in the BSA market, with a projected compound annual growth rate (CAGR) of 16.5% from 2021 to 2030. This rapid growth is driven by the expanding biopharmaceutical sector in countries like China, India, Japan, and South Korea. Government initiatives to strengthen the domestic biotech industry, such as increased funding for R&D and streamlined approvals, have bolstered BSA consumption. Leading global pharmaceutical companies have also established manufacturing hubs within China to serve the rising local demand and export to international markets. The live cattle population in India, one of the largest producers and consumers of BSA globally, ensures a steady supply. With burgeoning biomanufacturing industries, Asia Pacific's requirement for raw materials like BSA is expected to multiply in the near future.
Depending on the region, the market is divided into Asia Pacific (APAC), Europe, the Middle East and Africa (MEA), North America (NA) and Latin America (LA). The Asia Pacific region is predicted to lead the worldwide market in the following years. Increased use of albumin for the treatment of various diseases, increased research and development activities, and increased awareness of the therapeutic application of immunoglobin are some of the factors driving the bovine serum albumin market in the region. Australia and New Zealand are major producers of bovine serum albumin. In China, Japan, Korea, and India, increasing emphasis is placed on strengthening diagnosis, preventive care, and medical research. Due to these factors, these countries show great potential for growth in the bovine serum albumin market. China has played an important role in the growth of Asia in recent years and will be the main driver of this market. Furthermore, due to the maturity of the western market and the European recession, many albumin manufacturers have been drawn to the Asia Pacific region. The growing population in the Asia Pacific region offers the potential for expansion and adoption of a variety of medical treatments, including albumin products.
Major Key Players in the Global bovine serum albumin market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGAA, Itoham Yonekyu Holdings Inc, Proliant Biologicals, Kraeber & Co Gmbh, Rockland Immunochemicals Inc, Rocky mountain biologicals, Bio-Techne Corporation, Prospec-Tany Technogene Ltd and Others.
By Form
By Grade
By Vertical
By Region
Frequently Asked Questions
The Global Bovine Serum Albumin market can expand with a CAGR of 3% during the forecast period.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region